The heart attack diagnostic market size has grown strongly in recent years. It will grow from $11.54 billion in 2025 to $12.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic capabilities, improved availability of cardiac imaging technologies, increasing awareness of early heart attack detection, advancements in laboratory testing methods.
The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, growing integration of digital health platforms, expansion of remote cardiac monitoring, rising investments in advanced imaging technologies, increasing adoption of precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of ai-assisted diagnostic tools, rising use of high-sensitivity cardiac biomarkers, growing integration of point-of-care testing devices, expansion of non-invasive diagnostic procedures, enhanced focus on rapid emergency diagnostics.
The increasing prevalence of cardiac disorders is driving the growth of the heart attack diagnostics market. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels. Key contributors to heart disease and stroke include unhealthy diets, physical inactivity, tobacco use, and alcohol abuse. Diagnosing heart attacks is crucial for assessing the causes and severity of heart attacks, strokes, and heart failure. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK government entity, revealed that in 2023, over 1,862,500 individuals (3%) in England had received a GP diagnosis of coronary heart disease (CHD). This figure represents a decrease in the percentage of people diagnosed with CHD since the fiscal year ending in 2010. Consequently, the rising incidence of cardiovascular diseases is expected to continue fueling the heart attack diagnostics market.
Major companies in the heart attack diagnostics market are at the forefront of innovation, introducing groundbreaking products such as coronary heart disease detection tests. These tests are designed to identify the presence of coronary heart disease, characterized by the narrowing or blockage of coronary arteries. For instance, in August 2023, A notable product in this category is the PrecisionCHD test launched by Cardio Diagnostics Holdings Inc. This blood-based detection method for Coronary Heart Disease (CHD) uniquely integrates epigenetic and genetic biomarkers with Artificial Intelligence (AI). Notably, the PrecisionCHD test provides a rapid and efficient alternative to traditional CHD detection tools, offering convenience with a straightforward blood sample and swift results within 10 business days. This innovation reflects the commitment of major companies to meet evolving customer needs, drive sales, and elevate revenue in the heart attack diagnostics market.
In August 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired V-Wave Inc. for an undisclosed sum. This acquisition is part of Johnson & Johnson's strategy to enhance its portfolio, foster innovation, and broaden its market presence in the healthcare sector. V-Wave Inc., based in California, specializes in creating advanced medical devices and therapies aimed at managing heart failure.
Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc.
North America was the largest region in the heart attack diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the heart attack diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the heart attack diagnostic market by increasing costs of imported imaging equipment, diagnostic reagents, electronic sensors, and advanced monitoring systems. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher costs for advanced imaging equipment procurement. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging domestic manufacturing, local reagent production, and regional innovation in cost-efficient diagnostic solutions.
The heart attack diagnostic market research report is one of a series of new reports that provides heart attack diagnostic market statistics, including heart attack diagnostic industry global market size, regional shares, competitors with a heart attack diagnostic market share, detailed heart attack diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the heart attack diagnostic industry. This heart attack diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Heart attack diagnostics encompass methods for identifying, monitoring, screening, and prognosticating to validate the diagnosis of a heart attack. These diagnostics aid in determining the type of heart attack a patient has experienced, facilitating the selection of the most effective treatment. They play a crucial role in diagnosing heart disease.
The primary types of heart attack diagnostic tests include electrocardiogram (ECG/EKG), blood tests, X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI). These tests can be conducted through both invasive and non-invasive procedures. An electrocardiogram (ECG) is a rapid test that assesses the heart's electrical activity and rhythm by detecting signals produced during each heartbeat. It is valuable for diagnosing and monitoring heart-related conditions. These heart attack diagnostics are employed in various healthcare settings, including hospitals, ambulatory surgical centers, diagnostic centers, and other end-users.
The heart attack diagnostics market includes revenues earned by entities through tests such as stress tests, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and angiogram. The market value includes the value of related goods sold by the service provider or included within the service offering. The heart attack diagnostics market also includes sales of wearable ECG devices, cardiac pacemakers, stents, and ventricular assist devices (VADs) which are used in heart attack diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, growing integration of digital health platforms, expansion of remote cardiac monitoring, rising investments in advanced imaging technologies, increasing adoption of precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of ai-assisted diagnostic tools, rising use of high-sensitivity cardiac biomarkers, growing integration of point-of-care testing devices, expansion of non-invasive diagnostic procedures, enhanced focus on rapid emergency diagnostics.
The increasing prevalence of cardiac disorders is driving the growth of the heart attack diagnostics market. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels. Key contributors to heart disease and stroke include unhealthy diets, physical inactivity, tobacco use, and alcohol abuse. Diagnosing heart attacks is crucial for assessing the causes and severity of heart attacks, strokes, and heart failure. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK government entity, revealed that in 2023, over 1,862,500 individuals (3%) in England had received a GP diagnosis of coronary heart disease (CHD). This figure represents a decrease in the percentage of people diagnosed with CHD since the fiscal year ending in 2010. Consequently, the rising incidence of cardiovascular diseases is expected to continue fueling the heart attack diagnostics market.
Major companies in the heart attack diagnostics market are at the forefront of innovation, introducing groundbreaking products such as coronary heart disease detection tests. These tests are designed to identify the presence of coronary heart disease, characterized by the narrowing or blockage of coronary arteries. For instance, in August 2023, A notable product in this category is the PrecisionCHD test launched by Cardio Diagnostics Holdings Inc. This blood-based detection method for Coronary Heart Disease (CHD) uniquely integrates epigenetic and genetic biomarkers with Artificial Intelligence (AI). Notably, the PrecisionCHD test provides a rapid and efficient alternative to traditional CHD detection tools, offering convenience with a straightforward blood sample and swift results within 10 business days. This innovation reflects the commitment of major companies to meet evolving customer needs, drive sales, and elevate revenue in the heart attack diagnostics market.
In August 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired V-Wave Inc. for an undisclosed sum. This acquisition is part of Johnson & Johnson's strategy to enhance its portfolio, foster innovation, and broaden its market presence in the healthcare sector. V-Wave Inc., based in California, specializes in creating advanced medical devices and therapies aimed at managing heart failure.
Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc.
North America was the largest region in the heart attack diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the heart attack diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the heart attack diagnostic market by increasing costs of imported imaging equipment, diagnostic reagents, electronic sensors, and advanced monitoring systems. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher costs for advanced imaging equipment procurement. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging domestic manufacturing, local reagent production, and regional innovation in cost-efficient diagnostic solutions.
The heart attack diagnostic market research report is one of a series of new reports that provides heart attack diagnostic market statistics, including heart attack diagnostic industry global market size, regional shares, competitors with a heart attack diagnostic market share, detailed heart attack diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the heart attack diagnostic industry. This heart attack diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Heart attack diagnostics encompass methods for identifying, monitoring, screening, and prognosticating to validate the diagnosis of a heart attack. These diagnostics aid in determining the type of heart attack a patient has experienced, facilitating the selection of the most effective treatment. They play a crucial role in diagnosing heart disease.
The primary types of heart attack diagnostic tests include electrocardiogram (ECG/EKG), blood tests, X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI). These tests can be conducted through both invasive and non-invasive procedures. An electrocardiogram (ECG) is a rapid test that assesses the heart's electrical activity and rhythm by detecting signals produced during each heartbeat. It is valuable for diagnosing and monitoring heart-related conditions. These heart attack diagnostics are employed in various healthcare settings, including hospitals, ambulatory surgical centers, diagnostic centers, and other end-users.
The heart attack diagnostics market includes revenues earned by entities through tests such as stress tests, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and angiogram. The market value includes the value of related goods sold by the service provider or included within the service offering. The heart attack diagnostics market also includes sales of wearable ECG devices, cardiac pacemakers, stents, and ventricular assist devices (VADs) which are used in heart attack diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Heart Attack Diagnostic Market Characteristics
3. Heart Attack Diagnostic Market Supply Chain Analysis
4. Global Heart Attack Diagnostic Market Trends and Strategies
5. Heart Attack Diagnostic Market Analysis of End Use Industries
7. Global Heart Attack Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Heart Attack Diagnostic Total Addressable Market (TAM) Analysis for the Market
9. Heart Attack Diagnostic Market Segmentation
10. Heart Attack Diagnostic Market Regional and Country Analysis
11. Asia-Pacific Heart Attack Diagnostic Market
12. China Heart Attack Diagnostic Market
13. India Heart Attack Diagnostic Market
14. Japan Heart Attack Diagnostic Market
15. Australia Heart Attack Diagnostic Market
16. Indonesia Heart Attack Diagnostic Market
17. South Korea Heart Attack Diagnostic Market
18. Taiwan Heart Attack Diagnostic Market
19. South East Asia Heart Attack Diagnostic Market
20. Western Europe Heart Attack Diagnostic Market
21. UK Heart Attack Diagnostic Market
22. Germany Heart Attack Diagnostic Market
23. France Heart Attack Diagnostic Market
24. Italy Heart Attack Diagnostic Market
25. Spain Heart Attack Diagnostic Market
26. Eastern Europe Heart Attack Diagnostic Market
27. Russia Heart Attack Diagnostic Market
28. North America Heart Attack Diagnostic Market
29. USA Heart Attack Diagnostic Market
30. Canada Heart Attack Diagnostic Market
31. South America Heart Attack Diagnostic Market
32. Brazil Heart Attack Diagnostic Market
33. Middle East Heart Attack Diagnostic Market
34. Africa Heart Attack Diagnostic Market
36. Heart Attack Diagnostic Market Competitive Landscape and Company Profiles
37. Heart Attack Diagnostic Market Other Major and Innovative Companies
40. Heart Attack Diagnostic Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Heart Attack Diagnostic Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses heart attack diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for heart attack diagnostic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart attack diagnostic market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Test Type: Electrocardiogram (ECG Or EKG); Blood Tests; Echocardiogram; Coronary Catheterization (Angiogram)2) By Procedure: Invasive Procedure; Non-Invasive Procedure
3) By End-Use Industry: Hospitals; Ambulatory Surgical Centers; Diagnostics Centers; Other End-Users
Subsegments:
1) By Electrocardiogram (ECG Or EKG): Resting ECG; Holter Monitor; Event Monitor2) By Blood Tests: Cardiac Biomarkers; Lipid Panel; B-Type Natriuretic Peptide (BNP)
3) By Echocardiogram: Transthoracic Echocardiogram (TTE); Transesophageal Echocardiogram (TEE); Doppler Echocardiogram
4) By Coronary Catheterization (Angiogram): Coronary Angiography; Right Heart Catheterization; Left Heart Catheterization
Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; General Electric Co.; Koninklijke Philips NV; Siemens AG; Canon Medical Systems Corporation; GE Healthcare; Roche Diagnostics; Beckman Coulter Inc.; Schiller AG; Becton Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific Inc.; Quest Diagnostics; Bio-Rad Laboratories Inc.; Hitachi Ltd.; Toshiba Corp.; Fujifilm Holdings; Midmark Corp.; Welch Allyn Inc.; HILL ROM HOLDINGS Inc.; HeartFlow; Cardio Diagnostics Holdings Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Heart Attack Diagnostic market report include:- Abbott Laboratories
- F. Hoffmann-La Roche AG
- General Electric Co.
- Koninklijke Philips NV
- Siemens AG
- Canon Medical Systems Corporation
- GE Healthcare
- Roche Diagnostics
- Beckman Coulter Inc.
- Schiller AG
- Becton Dickinson and Company
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Quest Diagnostics
- Bio-Rad Laboratories Inc.
- Hitachi Ltd.
- Toshiba Corp.
- Fujifilm Holdings
- Midmark Corp.
- Welch Allyn Inc.
- HILL ROM HOLDINGS Inc.
- HeartFlow
- Cardio Diagnostics Holdings Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.64 Billion |
| Forecasted Market Value ( USD | $ 17.9 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
